{"id":53353,"date":"2012-10-02T14:30:09","date_gmt":"2012-10-02T14:30:09","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/houston-stem-cell-summit-announces-extraordinary-lineup-of-keynote-speakers.php"},"modified":"2012-10-02T14:30:09","modified_gmt":"2012-10-02T14:30:09","slug":"houston-stem-cell-summit-announces-extraordinary-lineup-of-keynote-speakers","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/houston-stem-cell-summit-announces-extraordinary-lineup-of-keynote-speakers.php","title":{"rendered":"Houston Stem Cell Summit Announces Extraordinary Lineup of Keynote Speakers"},"content":{"rendered":"<p><p>    HOUSTON, Oct. 1, 2012 \/PRNewswire\/ --The Houston Stem    Cell Summit will host an extraordinary lineup of keynote    speakers who represent the most accomplished stem cell    scientists, clinicians and entrepreneurs in the United    States. Joining these distinguished speakers will be    Governor of Texas, Rick Perry, consistent champion of adult    stem cell therapies.  <\/p>\n<p>    (Logo: <a href=\"http:\/\/photos.prnewswire.com\/prnh\/20120831\/NY66463LOGO\" rel=\"nofollow\">http:\/\/photos.prnewswire.com\/prnh\/20120831\/NY66463LOGO<\/a>    )  <\/p>\n<p>    The Houston Stem Cell Summit will be held October 26  27 in    its namesake city and will highlight the latest therapeutic    research regarding the use of adult stem and progenitor cell    therapies. The Summit will also provide a forum for    entrepreneurs to discuss their latest efforts to commercialize    stem cell therapies, and to debate and discuss FDA and other    legal and regulatory issues impacting stem cell research and    commercialization.  <\/p>\n<p>    Opening Keynote Address October 26, 2012  Arnold I. Caplan, PhD, Professor of Biology and    Professor of General Medical Sciences (Oncology) Case Western    Reserve University  <\/p>\n<p>    Dr. Caplan has helped shape the direction and focus of adult    stem cell research and commercialization. Virtually every adult    stem cell company and literally tens of thousands of research    papers are based on Dr. Caplan's original and ground breaking    research. Professor Caplan is considered to be the \"father\" of    the mesenchymal stem cell and first described this progenitor    cell in his landmark paper; \"Mesenchymal stem cells\", Journal    of Orthopaedic Research 1991;9(5):641-650. Since that    foundational study, Dr. Caplan has published over 360    manuscripts and articles in peer reviewed journals. Dr. Caplan    has been Chief Scientific Officer at OrthoCyte Corporation    since 2010. In addition, Dr. Caplan co-founded Cell Targeting    Inc. and has served as President of Skeletech, Inc. as its    founder. He is the recipient of several honors and awards from    the orthopedic research community. Dr. Caplan holds a Ph. D.    from Johns Hopkins University Medical School and a B.S. in    chemistry from the Illinois Institute of Technology.  <\/p>\n<p>    Summit Keynote Address October 26, 2012  Texas Governor Rick Perry  <\/p>\n<p>    Governor Perry is the 47th and current Governor of Texas.    Governor Perry has long championed the role of medical    technologies in building the future of not only Texas, but also    the United States. In many ways, his strong advocacy on behalf    of research and advanced medical technologies is one of his    strongest and as yet underappreciated legacies. In addition to    his service to the state of Texas, Governor Perry has also    served as Chairman of the Republican Governors Association in    2008 and again in 2011. Despite a rigorous schedule,    particularly in the teeth of this election season, Governor    Perry has graciously made time to speak and encourage the    researchers, patients, companies and physicians who form the    fabric and future of the stem cell therapy community.  <\/p>\n<p>    Texas Medical Center Keynote Address, October 27, 2012     James T. Willerson, MD  <\/p>\n<p>    Over the course of his career, Dr. James T. Willerson has    served as a medical, scientific and administrative leader for    each of the major institutions that are the foundation of the    Texas Medical Center. Dr. Willerson is currently President and    Medical Director, Director of Cardiology Research, and    Co-Director of the Cullen Cardiovascular Research Laboratories    at Texas Heart Institute (THI). Dr. Willerson was    appointed President-Elect of THI in 2004 and became President    and Medical Director in 2008. He is also an adjunct professor    of Medicine at Baylor College of Medicine and at The    University of Texas MD Anderson Cancer Center. He is the    former chief of Cardiology at St. Luke's Episcopal Hospital and    the former chief of Medical Services at Memorial Hermann    Hospital.  <\/p>\n<p>    Dr. Willerson has served as a visiting professor and invited    lecturer at more than 170 institutions.  <\/p>\n<\/p>\n<p>Visit link: <\/p>\n<p><a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/houston-stem-cell-summit-announces-154000374.html;_ylt=A2KJjbxi.mpQKUoAx1X_wgt.\" title=\"Houston Stem Cell Summit Announces Extraordinary Lineup of Keynote Speakers\">Houston Stem Cell Summit Announces Extraordinary Lineup of Keynote Speakers<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> HOUSTON, Oct. 1, 2012 \/PRNewswire\/ --The Houston Stem Cell Summit will host an extraordinary lineup of keynote speakers who represent the most accomplished stem cell scientists, clinicians and entrepreneurs in the United States. Joining these distinguished speakers will be Governor of Texas, Rick Perry, consistent champion of adult stem cell therapies <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/houston-stem-cell-summit-announces-extraordinary-lineup-of-keynote-speakers.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[25],"tags":[],"class_list":["post-53353","post","type-post","status-publish","format-standard","hentry","category-stem-cell-therapy"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/53353"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=53353"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/53353\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=53353"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=53353"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=53353"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}